Adamas
is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases... Read moreAdamas
is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases... Read more
CEO
Add
News
Jun 18, 2024
PR-Inside
Press Release: Adamas : Deadline Approaching for Receiving Share of Adamas Pharmaceuticals, ...
Jun 04, 2024
PR-Inside
Press Release: Adamas : Looming Deadline - Levi & Korsinsky Encourages Shareholders of Adamas ...
Apr 10, 2024
Pharamceutical Technology
Adamas: Adamas Pharmaceuticals gets grant for extended release amantadine for reducing sleep disturbances in parkinson's disease
Mar 25, 2023
Global Legal Chronicle
Adamas: Adamas Pharmaceuticals' False Claim Act Lawsuit
Nov 24, 2021
Citybizlist
Adamas: Supernus Pharmaceuticals Acquires Adamas Pharmaceuticals
Nov 02, 2021
EIN Presswire
Press Release: Adamas : Neil McFarlane, CEO of Adamas Pharmaceuticals honored by World Biz Magazine Awards with "Top 100 Innovation CEO" Award
Nov 01, 2021
The Business Journals: San Francisco Business Times
Adamas: East Bay drug maker's potential sale brings lawsuits, job cuts
Oct 27, 2021
MarketScreener
Adamas: ADAMAS ALERT: Bragar Eagel & Squire, P.C. Announces Commencement of Tender Offer and Encourages Investors to Contact the Firm
Oct 26, 2021
Seeking Alpha
Adamas: Adamas Pharmaceuticals: An Acceptable Buyout At The Perfect Time
Oct 21, 2021
MarketScreener
Adamas: Lifshitz Law Firm, P.C. Announces Investigation of ADMS, ACBI, FLXN, and HBMD
Adamas Competitors
1
2
3
4
5
6
7
8
9
10